Hospital-Based Surveillance and Analysis of Genotype Variation in Nicaragua After the Introduction of the Pentavalent Rotavirus Vaccine

201313 citationsJournal Article

Authors

Shazia Khawaja · Merck & Co., Inc., Rahway, NJ, USA (United States)

Abstract

No new or unexpected strains were predominant in the years immediately following the introduction of RV5 into Nicaragua. RV5 does not appear to have substantially altered the historical pattern of seasonal fluctuation in rotavirus genotypes.

Topics & Keywords

Viral gastroenteritis research and epidemiology Viral Infections and Immunology Research

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: The Pediatric Infectious Disease Journal

Volume 33, Issue 1, pp. e25-e28

DOI: 10.1097/inf.0000000000000074

Field-Weighted Citation Impact: 1.70